待处理
入排:排除
图源:待检查
Efficacy and safety of stapokibart (CM310) in adults with moderate-to-severe atopic dermatitis: A multicenter, randomized, double-blind, placebo-controlled phase 3 trial.
Yan Zhao, Litao Zhang, Jianzhong Zhang, CM310AD005 Study Investigators
J Am Acad Dermatol 91(5) 984-986
摘要
摘要
无摘要
KM 提取结果
0 个 Figure · 0 个 KM 面板